These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 21310726)

  • 1. Arterial spin labelling reveals an abnormal cerebral perfusion pattern in Parkinson's disease.
    Melzer TR; Watts R; MacAskill MR; Pearson JF; Rüeger S; Pitcher TL; Livingston L; Graham C; Keenan R; Shankaranarayanan A; Alsop DC; Dalrymple-Alford JC; Anderson TJ
    Brain; 2011 Mar; 134(Pt 3):845-55. PubMed ID: 21310726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arterial spin labeling detects perfusion patterns related to motor symptoms in Parkinson's disease.
    Rane S; Koh N; Oakley J; Caso C; Zabetian CP; Cholerton B; Montine TJ; Grabowski T
    Parkinsonism Relat Disord; 2020 Jul; 76():21-28. PubMed ID: 32559629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intracerebral hemodynamic abnormalities in patients with Parkinson's disease: Comparison between multi-delay arterial spin labelling and conventional single-delay arterial spin labelling.
    Wang X; Wang L; Wu Y; Lv X; Xu Y; Dou W; Zhang H; Wu J; Shang S
    Diagn Interv Imaging; 2024; 105(7-8):281-291. PubMed ID: 38310001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of Arterial Spin Labeling (ASL) Images in Parkinson's Disease (PD): A Systematic Review.
    Joshi D; Prasad S; Saini J; Ingalhalikar M
    Acad Radiol; 2023 Aug; 30(8):1695-1708. PubMed ID: 36435728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of visual and frontoparietal network perfusion deficits in Parkinson's disease dementia.
    Azamat S; Betul Arslan D; Erdogdu E; Kicik A; Cengiz S; Eryürek K; Tufekcioglu Z; Bilgic B; Hanagasi H; Demiralp T; Gurvit H; Ozturk-Isik E
    Eur J Radiol; 2021 Nov; 144():109985. PubMed ID: 34619619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparing cerebral perfusion in Alzheimer's disease and Parkinson's disease dementia: an ASL-MRI study.
    Le Heron CJ; Wright SL; Melzer TR; Myall DJ; MacAskill MR; Livingston L; Keenan RJ; Watts R; Dalrymple-Alford JC; Anderson TJ
    J Cereb Blood Flow Metab; 2014 Jun; 34(6):964-70. PubMed ID: 24619276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decline in drawing ability and cerebral perfusion in Parkinson's disease patients after subthalamic nucleus deep brain stimulation surgery.
    Furukawa S; Hirano S; Yamamoto T; Asahina M; Uchiyama T; Yamanaka Y; Nakano Y; Ishikawa A; Kojima K; Abe M; Uji Y; Higuchi Y; Horikoshi T; Uno T; Kuwabara S
    Parkinsonism Relat Disord; 2020 Jan; 70():60-66. PubMed ID: 31865064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic brain networks associated with cognitive function in Parkinson's disease.
    Huang C; Mattis P; Tang C; Perrine K; Carbon M; Eidelberg D
    Neuroimage; 2007 Jan; 34(2):714-23. PubMed ID: 17113310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Motor asymmetry related cerebral perfusion patterns in Parkinson's disease: An arterial spin labeling study.
    Shang S; Wu J; Zhang H; Chen H; Cao Z; Chen YC; Yin X
    Hum Brain Mapp; 2021 Feb; 42(2):298-309. PubMed ID: 33017507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tracking Cortical Changes Throughout Cognitive Decline in Parkinson's Disease.
    Filippi M; Canu E; Donzuso G; Stojkovic T; Basaia S; Stankovic I; Tomic A; Markovic V; Petrovic I; Stefanova E; Kostic VS; Agosta F
    Mov Disord; 2020 Nov; 35(11):1987-1998. PubMed ID: 32886420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cerebral blood flow deficits in Parkinson's disease with mild cognitive impairment using arterial spin labeling MRI.
    Arslan DB; Gurvit H; Genc O; Kicik A; Eryurek K; Cengiz S; Erdogdu E; Yildirim Z; Tufekcioglu Z; Uluğ AM; Bilgic B; Hanagasi H; Tuzun E; Demiralp T; Ozturk-Isik E
    J Neural Transm (Vienna); 2020 Sep; 127(9):1285-1294. PubMed ID: 32632889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Voxel-based quantitative susceptibility mapping in Parkinson's disease with mild cognitive impairment.
    Uchida Y; Kan H; Sakurai K; Arai N; Kato D; Kawashima S; Ueki Y; Matsukawa N
    Mov Disord; 2019 Aug; 34(8):1164-1173. PubMed ID: 31091347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Network basis of the dysexecutive and posterior cortical cognitive profiles in Parkinson's disease.
    Lang S; Hanganu A; Gan LS; Kibreab M; Auclair-Ouellet N; Alrazi T; Ramezani M; Cheetham J; Hammer T; Kathol I; Sarna J; Monchi O
    Mov Disord; 2019 Jun; 34(6):893-902. PubMed ID: 30924964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arterial spin labeling versus
    Dolui S; Li Z; Nasrallah IM; Detre JA; Wolk DA
    Neuroimage Clin; 2020; 25():102146. PubMed ID: 31931403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroimaging approaches to cognition in Parkinson's disease.
    Montaser-Kouhsari L; Young CB; Poston KL
    Prog Brain Res; 2022; 269(1):257-286. PubMed ID: 35248197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early-phase amyloid PET reproduces metabolic signatures of cognitive decline in Parkinson's disease.
    Aye WWT; Stark MR; Horne KL; Livingston L; Grenfell S; Myall DJ; Pitcher TL; Almuqbel MM; Keenan RJ; Meissner WG; Dalrymple-Alford JC; Anderson TJ; Heron CL; Melzer TR
    Alzheimers Dement (Amst); 2024; 16(2):e12601. PubMed ID: 38912306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Localised increase in regional cerebral perfusion in patients with visual snow syndrome: a pseudo-continuous arterial spin labelling study.
    Puledda F; Schankin CJ; O'Daly O; Ffytche D; Eren O; Karsan N; Williams SCR; Zelaya F; Goadsby PJ
    J Neurol Neurosurg Psychiatry; 2021 Sep; 92(9):918-926. PubMed ID: 34261750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictability of inter-regional cerebral perfusion similarity on dopamine responsiveness and the moderation role of cognition in PD patients.
    Cao Z; Wu C; Hong H; Huang P; Zhou C; Guan X; Wu H; Duanmu X; Xu X; Zhang M
    Neuroimage; 2023 Oct; 279():120305. PubMed ID: 37562719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormal regional brain function in Parkinson's disease: truth or fiction?
    Ma Y; Tang C; Moeller JR; Eidelberg D
    Neuroimage; 2009 Apr; 45(2):260-6. PubMed ID: 18992824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroimaging in Parkinson's disease.
    Brooks DJ
    NeuroRx; 2004 Apr; 1(2):243-54. PubMed ID: 15717025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.